United Community Bank’s Ionis Pharmaceuticals IONS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-1,131
Closed -$40.4K 234
2023
Q1
$40.4K Hold
1,131
0.04% 172
2022
Q4
$42.7K Buy
1,131
+5
+0.4% +$210 0.04% 178
2022
Q3
$49.8K Buy
1,126
+80
+8% +$3.37K 0.05% 174
2022
Q2
$38.7K Buy
1,046
+79
+8% +$2.98K 0.04% 180
2022
Q1
$35.8K Buy
967
+5
+0.5% +$164 0.04% 185
2021
Q4
$29.3K Buy
+962
New +$30.3K 0.03% 197

Other funds holding IONS

United Community Bank's IONS Position: Q2 2023 in Review

United Community Bank sold out of Ionis Pharmaceuticals (IONS) in Q2 2023, closing a stake of 1,131 shares — an estimated $40.4K sold.

United Community Bank first reported a position in IONS in Q4 2021 and held it in 6 quarters. The position peaked at $49.8K in Q3 2022. 304 funds tracked by Wall St. Rank hold IONS as of Q2 2023.

  • United Community Bank reported no remaining Ionis Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
  • United Community Bank sold 1,131 Ionis Pharmaceuticals shares in Q2 2023, an estimated $40.4K.
  • United Community Bank first reported a position in Ionis Pharmaceuticals in Q4 2021 and held it in 6 quarters.
  • United Community Bank's Ionis Pharmaceuticals position peaked at $49.8K in Q3 2022.
  • 304 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2023.

Based on United Community Bank's 13F filing for Q2 2023, filed 13 Feb 2024.